Judiciary Chair Nadler To Introduce Bill Ending ‘Pay For Delay’ Deals

By Chelsea Cirruzzo / March 8, 2019 at 6:57 PM
House Judiciary Chair Jerry Nadler (D-NY) said Thursday (March 7) that he plans to introduce a bipartisan bill to end so-called “pay for delay” deals between brand and generic drug makers. In pay-for-delay deals, a brand drug maker pays a generic competitor to abandon a patent challenge, delaying their entry into the market. “These agreements can be a win for both drug companies. The branded drug company gets to keep their monopoly and the generic company gets paid off with...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.